These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1478934)

  • 21. Association between extent of colonic mucosal sialomucin change and subsequent local recurrence after curative excision of primary colorectal cancer.
    Dawson PM; Habib NA; Fane S; Rees HC; Wood CB; Allen-Mersh TG
    Br J Surg; 1990 Nov; 77(11):1279-83. PubMed ID: 2253012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A MUC1/IL-18 DNA vaccine induces anti-tumor immunity and increased survival in MUC1 transgenic mice.
    Snyder LA; Goletz TJ; Gunn GR; Shi FF; Harris MC; Cochlin K; McCauley C; McCarthy SG; Branigan PJ; Knight DM
    Vaccine; 2006 Apr; 24(16):3340-52. PubMed ID: 16472547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of Sd(a)-sialomucin and sulfated H-sulfomucin in mouse small intestinal mucosa by infection with parasitic helminth.
    Tsubokawa D; Ishiwata K; Goso Y; Yokoyama T; Kanuka H; Ishihara K; Nakamura T; Tsuji N
    Exp Parasitol; 2015 Jun; 153():165-73. PubMed ID: 25819298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal antibody G47 engineered to be reactive with colorectal tumor mucin.
    Gold DV; Cardillo TM
    Hybrid Hybridomics; 2001; 20(5-6):343-50. PubMed ID: 11839252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucin secretion in inflammatory bowel disease: correlation with disease activity and dysplasia.
    Ehsanullah M; Filipe MI; Gazzard B
    Gut; 1982 Jun; 23(6):485-9. PubMed ID: 7076023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of sialomucins at the resection margin on survival of patients with colorectal cancer.
    Dawson PM; Habib NA; Wood CB
    Int Surg; 1987; 72(3):129-30. PubMed ID: 3679728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of sialomucin at the resection margin on local tumour recurrence and survival of patients with colorectal cancer: a multivariate analysis.
    Dawson PM; Habib NA; Rees HC; Williamson RC; Wood CB
    Br J Surg; 1987 May; 74(5):366-9. PubMed ID: 3297233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3rd International Workshop on Carcinoma-Associated Mucins, August 7-11 1994, Cambridge, UK.
    Brockhausen I
    Glycoconj J; 1995 Feb; 12(1):iv-v. PubMed ID: 7795406
    [No Abstract]   [Full Text] [Related]  

  • 29. Quantitative analysis of mRNA encoding MUC1, MUC2, and MUC5AC genes: a correlation between specific mucin gene expression and sialomucin expression in non-small cell lung cancer.
    Yu CJ; Shew JY; Shun CT; Lin HT; Kuo SH; Luh KT; Yang PC
    Am J Respir Cell Mol Biol; 1998 May; 18(5):643-52. PubMed ID: 9569234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sialomucin in middle ear cholesteatoma perimatrix.
    Nagai T; Kawano J; Suganuma T
    Acta Otolaryngol; 1992; 112(4):686-90. PubMed ID: 1279931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification by computerized morphometry of tissue levels of sulfomucins and sialomucins in diversion colitis in rats.
    Martinez CA; Nonose R; Spadari AP; Máximo FR; Priolli DG; Pereira JA; Margarido NF
    Acta Cir Bras; 2010 Jun; 25(3):231-40. PubMed ID: 20498935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the antigen recognized by monoclonal antibody 1D3.
    Gangopadhyay A; Chatterjee SK; Bhattacharya M; Barlow JJ
    Cancer Biochem Biophys; 1988 Nov; 10(2):107-15. PubMed ID: 3252956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predominance of sialomucin secretion in malignant and premalignant pancreatic lesions.
    Xerri L; Payan MJ; Choux R; Gros N; Figarella-Branger D; Sarles H
    Hum Pathol; 1990 Sep; 21(9):927-31. PubMed ID: 1697555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ectopic expression of mucins in colorectal cancer metastasis.
    Irimura T; Matsushita Y; Hoff SD; Yamori T; Nakamori S; Frazier ML; Giacco GG; Cleary KR; Ota DM
    Semin Cancer Biol; 1991 Apr; 2(2):129-39. PubMed ID: 1680492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation and partial characterization of ascites sialoglycoprotein-2 of the cell surface sialomucin complex of 13762 rat mammary adenocarcinoma cells.
    Hull SR; Sheng Z; Vanderpuye O; David C; Carraway KL
    Biochem J; 1990 Jan; 265(1):121-9. PubMed ID: 2302161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DU-PAN-2, mucin type differentiation antigen of normal and malignant pancreatic ductal cells.
    Metzgar RS; Lan MS; Kim YW; Koriwchak MJ; Mullins TD; Hollingsworth MA
    Prog Clin Biol Res; 1989; 288():53-61. PubMed ID: 2717641
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of tumor-associated antigens in the biology and immunotherapy of breast cancer.
    Taylor-Papadimitriou J; D'Souza B; Burchell J; Kyprianou N; Berdichevsky F
    Ann N Y Acad Sci; 1993 Nov; 698():31-47. PubMed ID: 8279769
    [No Abstract]   [Full Text] [Related]  

  • 38. Mucins in breast carcinoma.
    Hanna WM; Corkill M
    Hum Pathol; 1988 Jan; 19(1):11-4. PubMed ID: 2447006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serological identification of breast cancer-related antigens from a Saccharomyces cerevisiae surface display library.
    Wadle A; Mischo A; Imig J; Wüllner B; Hensel D; Wätzig K; Neumann F; Kubuschok B; Schmidt W; Old LJ; Pfreundschuh M; Renner C
    Int J Cancer; 2005 Oct; 117(1):104-13. PubMed ID: 15880534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sialomucin and lytic susceptibility of rat mammary tumor ascites cells.
    Moriarty J; Skelly CM; Bharathan S; Moody CE; Sherblom AP
    Cancer Res; 1990 Nov; 50(21):6800-5. PubMed ID: 2208144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.